News
New weight loss pill could benefit people with Type 2 diabetes: Drugmaker
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels on average by 1.3-1.6% and also help people lose up to 16 pounds, or about 7.9% of their body weight.
A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...
When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in ...
Nestlé unveils science-backed protein drinks to help manage hunger, support muscle health and aid weight loss for GLP-1 users ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback